Lv11
44 积分 2021-11-12 加入
[Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China（2024 edition）]
5小时前
待确认
Development of PROTAC Degrader Drugs for Cancer
1天前
已完结
PROTAC: Novel degradable approach for different targets to treat breast cancer
3个月前
已完结
Annual review of PROTAC degraders as anticancer agents in 2022
3个月前
已完结
A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer
3个月前
已完结
Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia
4个月前
已完结
[Updates in the 5(th) edition of WHO classification of tumours of the breast]
5个月前
已完结
Breast cancer classification: linking molecular mechanisms to disease prognosis
5个月前
已完结
Molecular Classification of Breast Cancer
5个月前
已完结
Molecular Classification of Breast Cancer
5个月前
已完结
皖公网安备34019202002308
